Amarin Appeals FDA Ruling On Fish Oil Drug's Expansion

Amarin Corp. PLC on Thursday appealed a U.S. Food and Drug Administration panel's denial of expanded use of its fish oil drug Vascepa among adults with high cholesterol levels, saying in a federal filing that the denial would harm the company's more

  • Tags: